DDW has announced the full agenda for its Drug Discovery Innovators & Investors (DDII) London, UK Conference – a full-day, in-person event focused on early-stage drug discovery and development.

This event is unique in its focus on early-stage drug discovery and development. From groundbreaking science and technology to regulation, funding and partnership, DDII offers insight on how to move a programme towards the clinic.

It brings together pharma and biotech companies, technology suppliers, academia, start-ups, spin-outs and investors in one room. No other event offers this perspective or level of drug discovery networking.

When: 4 November 2026

Where: etc.venues Monument, 8 Eastcheap, London, EC3M 1AE

What’s on the agenda

  • The UK’s global position: A keynote from Chris Molloy, CEO, UK BioIndustry Association (BIA), on positioning the UK as a high-value trading nation in medicines R&D.
  • Technology and innovation: Expert presentations on human organ-on-a-chip data that changes development decisions, plus the latest laboratory technologies as well as how to build a trusted data foundation for AI-enabled drug discovery.
  • AI in drug discovery: Concurrent sessions on AI in health economics and outcomes research, and on whether AI integration is the key to attracting investment.
  • Faster clinical trials: A panel on designing faster, more effective UK trials.
  • Regulation and IP: Expert presentations on navigating UK regulation, and on using commercially relevant IP to add value to discovery programmes.
  • Funding: A panel on securing investment for early-stage UK drug development in a difficult market.

Speakers include
Chris Molloy (BIA), Phillippa Brown (GSK, Janet Hemingway (iiCON), Dr Paul Brooks (CN Bio Innovations), Rob Walton (SPT Labtech), Tim Reason (Estima Scientific), Dr Wenshu Xu (TTP), Yogan Patel (MHA), Sam Goldsmith (Cell and Gene Therapy Catapult), Ayokunmi Ajetunmobi (Pioneer Group), Sinclair Dunlop (Epidarex), Tanya Moore (Cancer Research Horizons), Anusha Foy (Allucent), Dr Andrew Wells (HGF), and Thomas Averre (Tarleton Communications).

Built for connection
Dedicated 1:1 meetings and networking breaks run throughout the day, giving delegates the opportunity to connect with potential partners, suppliers, investors and collaborators.

Breakfast, lunch and refreshments are provided, followed by a networking drinks reception.

Early bird rates close 16 October.

[EXPLORE THE AGENDA & REGISTER NOW]

Breakout Sponsor: TTP